Archive open · compiled 23 Aug 2026

Source status is attached to every file

150Written inquiries transmitted June 21, 2026
0Substantive answers received
63Days elapsed as of August 23, 2026
UnansweredStatus of every inquiry below

How to read this register

Each item below reproduces one inquiry from the letter of June 21, 2026. In the letter, every inquiry used the same wrapper: “I would welcome an explanation regarding the following matter: [the matter]. I would be grateful to understand how it is structured or addressed, and to confirm whether my understanding is accurate.” That wrapper is shown once here rather than 150 times; the register below lists each matter and its source reference.

“Nothing in this letter is an accusation or a conclusion of wrongdoing. Each item below is an inquiry — a question I would be grateful to have answered or clarified. Many of these matters may have complete and ordinary explanations, and I welcome them.”

That framing from the letter governs this page as well: every entry is a question, not an assertion of fact or a finding of wrongdoing. The status label records only one fact — that no substantive answer has been received. Two inquiries concerning minor children are shown with initials in place of names. Responses to any inquiry are welcome and will be published through the response and corrections process.

Inquiries 1–13

Investment-Adviser Structure & Disclosures (Dalton / RCM / Rising Sun)

13 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 1 Unanswered

Whether RCM routes pooled-client assets into family-owned vehicles (including Beach Front), and how the client-consent and conflict-disclosure arrangements governing that are structured.

Reference: Form ADV

Inquiry 2 Unanswered

A single shared Chief Compliance Officer (Mr. Ha) serving both the controlling adviser (RCM) and the controlled adviser (Dalton), and how compliance independence is maintained between them.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 3 Unanswered

RCM's trading and recordkeeping being conducted by Dalton, the entity that RCM majority-owns, and how that arrangement is structured.

Reference: Form ADV

Inquiry 4 Unanswered

One Chief Investment Officer (Mr. Rosenwald III) allocating investment opportunities across the RCM, Rising Sun, NAVF, and Dalton books, which carry differing fee economics, and how those allocations are governed.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 5 Unanswered

Cross-trades among related-owned funds, and the written-client-approval mechanism the adviser relies on for principal transactions under Section 206(3).

Reference: Primary records provided in the accompanying evidence binder

Inquiry 6 Unanswered

The approval of Mr. Rosenwald III's outside directorships (Glass House, BFPM, Hogy) through the firm's compliance function, and how Item 11 outside-board approvals are handled.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 7 Unanswered

The Hogy Medical take-private, in which Mr. Rosenwald III served as an issuer director while advised funds tendered or reinvested, and how that transaction was handled.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 8 Unanswered

Whether the same individual carries two different Form ADV Part 2B biographies, with the Rovida/Roditi history appearing in the Dalton clients' version but not in the RCM clients' version, and how that difference arises.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 9 Unanswered

The RCM Part 2A describing the Family Trust as owning '100%' of RCM while Part 1 Schedule A codes the Trust at ownership code E (75% or more), and how those two figures reconcile.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 10 Unanswered

The basis for the Beach Front entity name appearing differently across same-day RCM filings ('Properties, LLC' in Part 1 versus 'Property Management, Inc.' in Part 2A/2B).

Reference: Primary records provided in the accompanying evidence binder

Inquiry 11 Unanswered

V.O.C. Investment Co. and other ICIJ offshore entities of which Mr. Rosenwald III was a director during Dalton's SEC-registration period, and whether and how they appear in the Form ADV Item 7.A / Item 10 disclosures.

Reference: ICIJ Offshore Leaks (public) record

Inquiry 12 Unanswered

Rising Sun Management operating as an unregistered relying adviser under RCM, and the conditions governing that relying-adviser arrangement.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 13 Unanswered

The ERISA-pension cross-trade and affiliated-investment exposure on the FedEx, Northrop, and Resolute mandates, and how it is addressed under the Advisers Act and ERISA.

Reference: Primary records provided in the accompanying evidence binder

Inquiries 14–26

Related-Party & Intercompany Arrangements

13 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 14 Unanswered

Whether RCM routes pooled-client assets into Dalton and Beach Front vehicles in which the family holds an interest, and how the associated fee layers are structured.

Reference: Form ADV

Inquiry 15 Unanswered

Whether Dalton provides RCM and Rising Sun their back-office, compliance, and trading functions for a fee under one shared CCO, and how that arrangement is structured.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 16 Unanswered

The Beach Front $2M note and Kings Bay ~$1.925M note and their conversion into GH Group preferred held by the founder family, and how that conversion was structured.

Reference: Glass House Brands 40-F

Inquiry 17 Unanswered

The ~$1.5M/yr related-party preferred dividends paid by Glass House to the founder/family affiliated holders, and how that arrangement is structured and disclosed.

Reference: Glass House Brands 40-F

Inquiry 18 Unanswered

The BFPM consulting fee ($140k/yr) paid by Glass House to a founder-majority-owned manager, and how that arrangement is structured and disclosed.

Reference: Glass House Brands 6-K

Inquiry 19 Unanswered

The Jon A. Neu Insurance brokerage fees paid by Glass House to a BFPM-owned insurance arm, and how the disclosure differs between FY2024 and FY2025.

Reference: Glass House Brands 40-F

Inquiry 20 Unanswered

The four additional founder-affiliated real-estate leases under which rent is paid by Glass House to insider-owned landlords, and how those leases are structured and disclosed.

Reference: Glass House Brands 6-K

Inquiry 21 Unanswered

Jocelyn Rosenwald's role chairing the Audit Committee that oversees related-party transactions, together with her founder/preferred economic interests in the counterparties, and how any conflict is addressed.

Reference: Glass House Brands 40-F

Inquiry 22 Unanswered

Kazan's roles as Glass House CEO and Beach Front chair in relation to the GH/Beach Front related-party contracts, and how any conflict on those contracts is addressed.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 23 Unanswered

The July 1, 2019 repositioning of the JBR IV Trust through RCM, and how it was structured.

Reference: Form ADV

Inquiry 24 Unanswered

RCM serving as statutory co-manager of Beach Front Properties LLC while Mr. Rosenwald III sits as a BFPM director, and the ownership percentage involved.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 25 Unanswered

Benno's 'Orinoco Foundation' compensation being paid via RCM, as stated in the financial affidavit, and how that arrangement is structured.

Reference: the dissolution financial affidavit (in the case record)

Inquiry 26 Unanswered

Whether any ERISA plan assets have exposure to Glass House Brands through Dalton-managed funds.

Reference: Department of Labor Form 5500

Inquiries 27–35

Corporate Governance & Director Roles

9 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 27 Unanswered

Jocelyn Rosenwald's role chairing the Glass House audit committee together with her position as a co-founder, daughter of the ~14% voting holder, and a family beneficiary of the related-party flows the committee reviews, and how any conflict is addressed.

Reference: Glass House Brands 40-F

Inquiry 28 Unanswered

The Series E related-party financing being routed through the Delaware operating subsidiary (GH Group) rather than the BC parent, and how the MI 61-101 minority-approval and valuation requirements were applied.

Reference: Glass House Brands 40-F

Inquiry 29 Unanswered

The nature of Mr. Rosenwald III's three simultaneous capacities in relation to Glass House — an approximately 10% holder, a 'control or direction' insider, and the adviser-CIO whose advisory pool (per RCM ADV 10(E)) invests client capital into the family vehicles — and how any conflict is addressed.

Reference: Form ADV

Inquiry 30 Unanswered

Mr. Rosenwald III's seat on the Hogy Medical board in relation to the family-controlled bloc's tender of its approximately 26-27% stake into a Carlyle take-private with an up-to-approximately 20% LP rollover, and how that transaction was structured.

Reference: Japan EDINET large-shareholding report

Inquiry 31 Unanswered

A single shared Chief Compliance Officer (Christopher Ha), and historically a single GC/CCO (Michelle Lynd), over RCM, Dalton, Rising Sun, and the NAVF Select funds, and how independent compliance oversight is maintained across the commonly-controlled advisers.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 32 Unanswered

Interlocking directors among Dalton's pension clients (Mr. Turley serving on Citigroup and Northrop; Ms. Ovrum on TechnipFMC and FMC) and any Clayton Act Section 8 considerations.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 33 Unanswered

Two seated Dalton/RSM directors at Helios Techno (Nishida and Mizuochi) plus a negotiated Anicom seat (Hayashi), and how the director-fee income and board roles are handled.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 34 Unanswered

Whether three Rosenwald family members (JBR III, Jocelyn, Ha) serve simultaneously on the officer/director rolls of both SEC advisers (RCM and Dalton), and how any related-party governance is handled.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 35 Unanswered

The audit-committee chair's insider-reporting timeliness under NI 55-104, and how that reporting is handled.

Reference: Canadian SEDI insider-transaction record

Inquiries 36–41

Retirement-Plan (ERISA) Management

6 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 36 Unanswered

Dalton's designation as ERISA Section 3(38) investment manager on the Northrop Grumman DB Master Trust, and the scope of that fiduciary role.

Reference: Department of Labor Form 5500, Schedule C

Inquiry 37 Unanswered

Disney and Willis Towers Watson holding Dalton commingled funds as eligible-indirect-compensation / Schedule H 4i holdings, and how the associated fees are reported.

Reference: Department of Labor Form 5500, Schedule C

Inquiry 38 Unanswered

Whether Dalton's Form ADV discloses the Glass House Brands / cannabis affiliation to its ERISA pension clients.

Reference: Form ADV

Inquiry 39 Unanswered

Whether any Dalton-sponsored 103-12 IE or DFE Form 5500 exists for the affiliated funds.

Reference: Department of Labor Form 5500

Inquiry 40 Unanswered

Whether any RCM, Rising Sun, or Kings Bay client is an ERISA plan.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 41 Unanswered

The YMCA Retirement Fund's status as a church plan exempt from ERISA, given that it is among Dalton's largest non-profit clients (approximately $2.13M per year).

Reference: Primary records provided in the accompanying evidence binder

Inquiries 42–47

U.S. Securities — Ownership & Reporting

6 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 42 Unanswered

NAVF Select LLC (the domestic feeder) standing at 88 of the 100-investor ceiling for its claimed Section 3(c)(1) exemption, and how the Form D / Investment Company Act limits are monitored.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 43 Unanswered

NAVF Select (Offshore Fund) Ltd.'s Form D claiming only 3(c)(1) with no Reg D exemption item, and which Securities Act exemption (Reg S or Reg D) is relied upon.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 44 Unanswered

The application of Regulation FD to the Glass House Brands disclosures, given the company's foreign-private-issuer status.

Reference: Glass House Brands 40-F

Inquiry 45 Unanswered

Whether the GH Group / Glass House related-party preferred and note conversions relied on private-placement exemptions from Securities Act registration.

Reference: Glass House Brands 40-F

Inquiry 46 Unanswered

Whether the late or bunched SEDI insider filings carry any U.S. securities-reporting obligation in addition to the Canadian one.

Reference: Canadian SEDI insider-transaction record

Inquiry 47 Unanswered

The difference between the approximately 9.3% voting figure and the approximately 0.18% combined-voting-power figure reported for Jocelyn Rosenwald, and the underlying multiple-voting-share holdings by holder.

Reference: Glass House Brands 6-K

Inquiries 48–56

Canadian Securities — Insider & Early-Warning Reporting

9 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 48 Unanswered

Mr. Rosenwald III's SEDI insider-reporting filing timeliness, including the at least 15 personally-filed filings made late (the latest approximately 262 days late) across 2022, February 2025, and August 2025, and how those filing timelines are explained.

Reference: Canadian SEDI insider-transaction record

Inquiry 49 Unanswered

The August 21, 2025 cluster of four SEDI filings, which were filed approximately 246 days after the underlying transactions, and how the timing under NI 55-104 is explained.

Reference: Canadian SEDI insider-transaction record

Inquiry 50 Unanswered

The SEDI filing-timeliness record at Glass House beyond the Rosenwalds — the DeCourcey (373-day) and Payne (64-day) opening-balance filings, and the Kazan/Farrar (371-/72-day) option-exercise filings — and the disclosure controls in place.

Reference: Canadian SEDI insider-transaction record

Inquiry 51 Unanswered

Jocelyn Rosenwald's January 10, 2026 RSU-settlement filing and the approximately 47 business / 53 calendar days between the event and the filing, and how that timing is explained.

Reference: Canadian SEDI insider-transaction record

Inquiry 52 Unanswered

The Hogy Medical take-over and Mr. Rosenwald III's director role in relation to it, and the timeliness of the tender-contract filing.

Reference: Japan EDINET large-shareholding report

Inquiry 53 Unanswered

The MI 61-101 related-party minority-protection treatment of the GH Group Series E ($13.0M) refinancing, which was routed through the Delaware operating subsidiary rather than the BC reporting issuer and disclosed as a related-party transaction.

Reference: Glass House Brands 40-F

Inquiry 54 Unanswered

Glass House's transition from foreign-private-issuer SEDI reporting toward U.S. Section 16 reporting (Form 3/4 and Form 144) in 2026.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 55 Unanswered

The continuation of the Multiple Voting Shares' 50:1 voting past the stated June 29, 2024 sunset, and whether an amending resolution exists.

Reference: Glass House Brands information circular

Inquiry 56 Unanswered

The complete liquidation of the Kings Bay (Cayman Islands) Glass House Brands position to zero in December 2025 (approximately $2.57 million across six trades in one week).

Reference: Canadian SEDI insider-transaction record

Inquiries 57–65

Japanese Securities — Large-Shareholding & Tender-Offer Matters

9 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 57 Unanswered

Nasu Denki-Tekko (TSE 5922) and the FIEA Section 27-25(1) amendment that was filed one business day after the deadline, and how that filing timing is addressed.

Reference: Japan EDINET large-shareholding report

Inquiry 58 Unanswered

The FIEA filing-timeliness across the bloc, including the extent of last-day filing reflected in the reports.

Reference: Japan EDINET large-shareholding report

Inquiry 59 Unanswered

How the concert-party (kyodo hoyu) holdings are aggregated and reported across the joint filings.

Reference: Japan EDINET large-shareholding report

Inquiry 60 Unanswered

How FIEA Articles 166/167 apply to the 60-day transaction tables around the Hogy/Carlyle tender offer.

Reference: Japan EDINET large-shareholding report

Inquiry 61 Unanswered

How Mr. Rosenwald III's seat on the Hogy Medical board relates to the tender of the family bloc and to any carried interest.

Reference: Japan EDINET large-shareholding report

Inquiry 62 Unanswered

How the Dalton/Rising Sun directorships at Helios Techno (TSE 6927) are structured, including the two currently-seated directors and the 28.74% bloc held during the third-party tender offer, and the director-fee arrangements.

Reference: Japan EDINET large-shareholding report

Inquiry 63 Unanswered

The 2024 FIEA reform (effective May 1, 2026) lowering the mandatory tender-offer threshold to 30% and extending it to on-market purchases, and the Eiken Chemical (4549) bloc position of approximately 32.8% relative to that threshold.

Reference: Japan EDINET large-shareholding report

Inquiry 64 Unanswered

Whether there has been any SESC/FSA enforcement, recommendation (kankoku), or surcharge (kachokin) against Dalton, NAVF, NAVF Select, Rising Sun, Dalton Advisory KK, or any Rosenwald principal.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 65 Unanswered

The nature and basis of the disclosed activist intent (hoyu mokuteki / juyo teian koi to) described in the EDINET reports.

Reference: Japan EDINET large-shareholding report

Inquiries 66–75

U.K./E.U. Fund Matters (Nippon Active Value Fund)

10 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 66 Unanswered

How the NAVF IPO holding (RCM TR-1 = 37.44%) relates to the 30% level and the prospectus statement about staying sub-30% to avoid a Rule 9 mandatory bid.

Reference: Nippon Active Value Fund prospectus

Inquiry 67 Unanswered

The family adviser (Rising Sun) advising the listed plc while the family is its largest shareholder, and how that conflict is managed.

Reference: Nippon Active Value Fund prospectus

Inquiry 68 Unanswered

How NAVF's choice of the Specialist Fund Segment and its voluntary compliance with the related-party (Chapter 11) listing-rule protections are structured.

Reference: Nippon Active Value Fund prospectus

Inquiry 69 Unanswered

The Shore Capital relationship as IPO sponsor/broker, including its 15% ownership of the family adviser and JBR III's seat on Shore Capital's board, and how the potential conflict is addressed.

Reference: Nippon Active Value Fund prospectus

Inquiry 70 Unanswered

The Companies House PSC register naming James 'Benno' Rosenwald and Laura Parker Rosenwald as 75%-or-more PSCs at NAVF incorporation.

Reference: UK Companies House record

Inquiry 71 Unanswered

Whether the Japan concert-party voting bloc fronted by the FCA-regulated UK listed vehicle raises any UK-side disclosure question.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 72 Unanswered

How the NAVF regulatory structure — third-party AIFM (FundRock Guernsey), independent board, and BDO as auditor — is constituted and how independent it is from the family.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 73 Unanswered

The Longchamp Dalton and Lafayette Dalton UCITS funds run via independent EU management companies, and the noted deregistration.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 74 Unanswered

The nature and terms of the FCA-regulated UK third-party mandate (Alliance Witan) held by Rising Sun/Dalton.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 75 Unanswered

NAVF's 2023 absorption of the abrdn Japan and Atlantis Japan trusts while RCM held approximately 34%, and the related-party governance applied under the voluntary policy.

Reference: Nippon Active Value Fund prospectus

Inquiries 76–86

Tax & Offshore-Entity Reporting

11 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 76 Unanswered

JBR III's FBAR (FinCEN 114) reporting obligations over the Cayman/Bermuda offshore-entity portfolio (Kings Bay, Rovida, V.O.C., Asia Securitas, DOIT, Dalton Cayman feeders).

Reference: Form ADV

Inquiry 77 Unanswered

JBR III's Form 5471 reporting obligations (for U.S. officers, directors, or shareholders of foreign corporations) across the same Cayman/Bermuda corporations.

Reference: ICIJ Offshore Leaks (public) record

Inquiry 78 Unanswered

JBR III's Form 8938 (FATCA) specified-foreign-financial-asset reporting obligations arising from his offshore-entity interests.

Reference: ICIJ Offshore Leaks (public) record

Inquiry 79 Unanswered

PFIC (Form 8621) exposure for any U.S. person holding Nippon Active Value Fund plc or the Cayman offshore feeder funds.

Reference: Nippon Active Value Fund prospectus

Inquiry 80 Unanswered

The grantor-trust characterization and Form 1041 treatment of the JBR IV Trust (the vehicle through which the Glass House Brands shares are held).

Reference: Canadian SEDI insider-transaction record

Inquiry 81 Unanswered

Whether the Kings Bay GLASF liquidation (drawn to zero in approximately December 2025, approximately $2.57M) and the July 2025 Glass House Series E related-party preferred exchange are taxable events for the family sleeves.

Reference: Canadian SEDI insider-transaction record

Inquiry 82 Unanswered

The Orinoco Trust named as Laura Parker Rosenwald's FEC 'employer,' and whether it is an income-producing trust requiring Form 1041 and family-income reporting.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 83 Unanswered

Whether the Form ADV Schedule D 7.B disclosure of Kings Bay and Rosenwald Partners corresponds to any separate FBAR, Form 5471, or Form 8938 reporting for those entities.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 84 Unanswered

The FBAR and related foreign-reporting obligations associated with Kings Bay and James B. Rosenwald III's directorship of it.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 85 Unanswered

The Hogy Medical approximately 27.58% tender into the Carlyle take-private (March 2026) and the carried-interest / capital-gain characterization for tax purposes.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 86 Unanswered

Whether Forms 3520/3520-A (foreign-trust reporting) and Form 8865 (foreign-partnership reporting) apply to the family trusts and offshore vehicles.

Reference: Primary records provided in the accompanying evidence binder

Inquiries 87–93

Securities-Trading Timing & Disclosure

7 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 87 Unanswered

The timing of JBR III's GLASF dispositions relative to public disclosures and positive catalysts.

Reference: Glass House Brands 40-F

Inquiry 88 Unanswered

The late and bunched SEDI insider-report filings (the August 21, 2025 cluster filed approximately 246 days late) and the associated disclosure timeliness.

Reference: Canadian SEDI insider-transaction record

Inquiry 89 Unanswered

The timing of the Kings Bay liquidation relative to the December 2025 cannabis-rescheduling developments, including the December 15-16 sales of 150,000 shares ahead of the public executive order and the company's December 20 press release.

Reference: Glass House Brands 40-F

Inquiry 90 Unanswered

The Hogy Medical / Carlyle take-private (December 2025), in which JBR III sat on Hogy's board while Dalton (a 15.2% holder) tendered, contemporaneous with the GLASF December liquidation.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 91 Unanswered

Whether any Rule 10b5-1 / automatic-disposition plan covers JBR III's GLASF sales.

Reference: Glass House Brands 40-F

Inquiry 92 Unanswered

The GLASF insider selling activity (the Vendetti/Farrar/El Tabsh/Vega four-officer cycles, and the March 23, 2026 CFO block), and how it is structured or addressed.

Reference: Canadian SEDI insider-transaction record

Inquiry 93 Unanswered

Whether the voting power shown on the SEDI insider record reflects the Multiple Voting Shares' continued 50:1 voting after the stated June 29, 2024 sunset.

Reference: Canadian SEDI insider-transaction record

Inquiries 94–100

Cannabis-Related Regulatory & Valuation Matters (Glass House)

7 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 94 Unanswered

Glass House Brands' disclosed cannabis exposure as 100% U.S. (federally Schedule-I) cannabis, and the disclosed 'forfeiture of entire investment' risk, and how that exposure is characterized for the marital estate's GLASF stake (including Benno via the JBR IV Trust).

Reference: Glass House Brands 40-F

Inquiry 95 Unanswered

The IRC 280E tax positions Glass House discloses — $31.7M cumulative unrecognized tax benefits 'based on legal interpretations that challenge the Company's tax liability under Section 280E' — and how they are structured.

Reference: Glass House Brands 40-F

Inquiry 96 Unanswered

Whether the Rosenwald family members are disclosed to the California DCC as statutory 'Owners' / financial-interest holders of the license-holding GH subsidiaries.

Reference: Glass House Brands information circular

Inquiry 97 Unanswered

The DCC management-disqualification disclosure that GLASF makes — 'management team or other owners could be disqualified from ownership' — and how a Rosenwald owner's conduct or non-disclosure would bear on the licenses.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 98 Unanswered

The cannabis-banking situation that Glass House Brands discloses, including the absence of a federal statutory safe harbor for banks serving cannabis businesses.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 99 Unanswered

Whether the charitable foundations (Abrons, Rita Allen, Rippel) and the YMCA Retirement Fund have any indirect cannabis / Glass House exposure through Dalton-managed funds.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 100 Unanswered

The nature and basis of the cannabis-related related-party flows to the Rosenwald family (BFPM consulting, Jon A. Neu Insurance, and GH Group preferred dividends).

Reference: Glass House Brands 40-F

Inquiries 101–105

Charitable & Non-Profit Matters

5 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 101 Unanswered

The affidavit statement that Benno's 'Orinoco Foundation' salary is paid via Rosenwald Capital Management, and how the foundation itself is organized and governed.

Reference: the dissolution financial affidavit (in the case record)

Inquiry 102 Unanswered

Whether the Orinoco Foundation (EIN 23-7373741) appears in IRS Pub 78 and how its $0 reported figure squares with the sworn statement that it pays Benno's RCM-routed salary.

Reference: the dissolution financial affidavit (in the case record)

Inquiry 103 Unanswered

RCM's only non-fund account being an unnamed charitable-organization separately managed account ($89,802,428), and the identity of that organization and any family relationship to it.

Reference: Form ADV

Inquiry 104 Unanswered

The YMCA Retirement Fund's Schedule L identification of Dalton Investments LLC as a 'substantial contributor' interested person ($2,133,361) while paying it the identical sum as its investment manager.

Reference: IRS Form 990

Inquiry 105 Unanswered

Whether the Abrons, Rita Allen, and Rippel private foundations holding Dalton-managed funds involve any Rosenwald or Dalton person on their boards.

Reference: Primary records provided in the accompanying evidence binder

Inquiries 106–124

Marital-Estate, Income & Asset-Disclosure Matters

19 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 106 Unanswered

The nature and timing of the approximately $7.97 million in Glass House Brands sales, including the Kings Bay liquidation, that occurred during the pendency of this action.

Reference: Canadian SEDI insider-transaction record

Inquiry 107 Unanswered

The role of the Family Trust in funding personal expenses and its characterization in Benno's financial affidavit.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 108 Unanswered

The court's finding regarding the trust-distribution source and the relationship between that source and the income used to determine alimony.

Reference: the Memorandum of Decision (in the case record)

Inquiry 109 Unanswered

The July 1, 2019 restructuring of the Dalton ownership (55 days before the marriage) and its effect on the interests held through the family trusts.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 110 Unanswered

Whether the JBR IV Trust appears as an indirect owner on the RCM Schedule A, and how Benno's Dalton/RCM beneficial interest is reflected on the marital balance sheet.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 111 Unanswered

The nature and terms of the rent-free occupancy of 923 Fifth Avenue, Apartment 4C (approximately $360,000 per year in fair rental value; approximately $2.09 million open mortgage).

Reference: Primary records provided in the accompanying evidence binder

Inquiry 112 Unanswered

The basis for the estimate of Benno's earning capacity (approximately $1.16M per year) relative to the reported $312K W-2, and the corporate-card / trust-conduit funding of household expenses.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 113 Unanswered

The $1.45M settlement note and the $1.2M joint-Schwab commitment, and how they appear on Benno's financial affidavit.

Reference: the dissolution financial affidavit (in the case record)

Inquiry 114 Unanswered

The minor child A.R.'s separate Rosenwald Partners LP interest, and whether it appears on Benno's affidavit.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 115 Unanswered

The minor child E.R.'s separate Rosenwald Partners LP interest, and whether it appears on Benno's affidavit.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 116 Unanswered

The nature and terms of the approximately $23 million intra-family migration of Glass House Brands shares to Jocelyn Rosenwald between the first and second quarters of 2026, during the pendency of this action.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 117 Unanswered

The 2026 intra-family promissory notes and encumbrances and their effect on reportable net worth.

Reference: the dissolution financial affidavit (in the case record)

Inquiry 118 Unanswered

The status of the $5,000 per month alimony order and the $24,980 arrears wire that was returned rather than received.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 119 Unanswered

The pendente-lite alimony award relative to the marital standard of living (reported at approximately $50K per month).

Reference: the Memorandum of Decision (in the case record)

Inquiry 120 Unanswered

The effect of the $5,000 per month award on housing eligibility, given landlord income and asset screening requirements.

Reference: the Memorandum of Decision (in the case record)

Inquiry 121 Unanswered

The California payroll tax reflected for a sworn Connecticut resident, and the underlying economic domicile (the RCM / Redondo Beach hub).

Reference: Primary records provided in the accompanying evidence binder

Inquiry 122 Unanswered

How 15 Horseshoe Road (Cos Cob), reported at full fair market value, is treated in relation to a $1 million family-trust acquisition note, and whether that note has been disclosed.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 123 Unanswered

The LASC 26STCV10838 action (in which RCM is a named defendant) and its relationship to the marital-estate assets.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 124 Unanswered

The nature of the approximately $262 million Hogy Medical exit as a realization event and how it affects the Family-Trust Dalton equity.

Reference: Primary records provided in the accompanying evidence binder

Inquiries 125–131

Beneficial-Ownership, AML & Sanctions Matters

7 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 125 Unanswered

Whether any Rosenwald Cayman entity registered to do business in a U.S. state is a 'foreign reporting company' with a Corporate Transparency Act beneficial-ownership-information obligation, given the U.S.-person and foreign-pooled-investment-vehicle carve-outs.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 126 Unanswered

The Glass House cannabis-derived cash flows to family-affiliated channels (BFPM consulting, Jon A. Neu insurance, and preferred dividends), and any Bank Secrecy Act considerations.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 127 Unanswered

The offshore captive-reinsurance arrangement (St. Kitts Reinsurance Ltd to Pride Specialty Insurance Ltd; Nevis, then Cayman, 2023) and its structure.

Reference: Primary records provided in the accompanying evidence binder

Inquiry 128 Unanswered

The entities identified in FEC records as employers (Orinoco Trust; Dalton Northwest) and their relationship to the family enterprise.

Reference: Form ADV

Inquiry 129 Unanswered

The Kings Bay December 2025 liquidation to zero (approximately $2.57 million in one week) and the timeliness of the related SEDI filings, including the 14 late filings (the August 2025 cluster filed 246 days after the trades).

Reference: Canadian SEDI insider-transaction record

Inquiry 130 Unanswered

Any OFAC or sanctions considerations applicable to the Japanese, Korean, and other Asian holdings and counterparties.

Reference: Japan EDINET large-shareholding report

Inquiry 131 Unanswered

The cross-entity capital flows from RCM pooled-vehicle clients into family-affiliated vehicles disclosed in Form ADV Item 10.E.

Reference: Primary records provided in the accompanying evidence binder

Inquiries 132–138

Paycheck Protection Program (PPP) Loans (2020–2021)

7 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 132 Unanswered

The Dalton Investments LLC Paycheck Protection Program loan of $665,600 (approved April 14, 2020, MidFirst Bank, SBA loan number 5923317103, NAICS 523920 — portfolio management), forgiven in full ($672,903.11) on May 21, 2021 while the firm was an SEC-registered investment adviser, and how the eligibility and the certification that adequate credit was not available elsewhere are addressed.

Reference: U.S. Small Business Administration PPP FOIA dataset (loan no. 5923317103)

Inquiry 133 Unanswered

The Rosenwald Capital Management, Inc. PPP loan of $123,600 made the same day (April 14, 2020, U.S. Bank, SBA loan number 6351357102, NAICS 523930 — investment advice), forgiven in full ($124,737.80) while the firm was an SEC-registered investment adviser, and how its eligibility is addressed.

Reference: U.S. SBA PPP FOIA dataset (loan no. 6351357102)

Inquiry 134 Unanswered

The Beach Front Property Management, Inc. First Draw PPP loan of $1,641,372 (April 12, 2020, Farmers & Merchants Bank of Long Beach, SBA loan number 4090457110, NAICS 531311), reporting 277 jobs, forgiven in full ($1,656,526.59), and how its eligibility is addressed.

Reference: U.S. SBA PPP FOIA dataset (loan no. 4090457110)

Inquiry 135 Unanswered

The Beach Front Property Management, Inc. Second Draw PPP loan of $1,644,000 (February 1, 2021, SBA loan number 1313348407), reporting 281 jobs, forgiven in full ($1,653,728.88), and how the separate certification of a 25% or greater revenue decline was addressed.

Reference: U.S. SBA PPP FOIA dataset (loan no. 1313348407)

Inquiry 136 Unanswered

The John A. Neu Insurance Services, Inc. PPP loan of $147,177.50 (April 28, 2020, American Business Bank, SBA loan number 8046927208, NAICS 524210), forgiven in full ($148,693.63), and how its eligibility is addressed.

Reference: U.S. SBA PPP FOIA dataset (loan no. 8046927208)

Inquiry 137 Unanswered

A Nevada entity named 'Dalton Investments Inc.' that received a PPP loan of $22,524 (May 1, 2020, Wells Fargo Bank, SBA loan number 4922267704, with a blank NAICS code and HUBZone and LMI certifications), forgiven in full ($22,738.75), and how this 'Inc.' entity relates to the documented February 2024 conversion of Dalton Investments LLC to Dalton Investments, Inc.

Reference: U.S. SBA PPP FOIA dataset (loan no. 4922267704)

Inquiry 138 Unanswered

The approximately $4,244,273 in PPP funds received across these entities, all forgiven in full (approximately $4,279,329), and how the eligibility and certifications supporting the loans and their forgiveness are addressed. I would be grateful to understand the eligibility and certifications supporting the loans and their forgiveness.

Reference: U.S. SBA PPP FOIA dataset, release 240930

Inquiries 139–146

Offshore Entities (ICIJ Offshore Leaks / Paradise Papers)

8 inquiries in this group. Each remains unanswered as of August 23, 2026.

Inquiry 139 Unanswered

The offshore entities with which James B. Rosenwald III is associated as an officer in the ICIJ Offshore Leaks (Paradise Papers / Appleby) records, and their current status and purpose.

Reference: ICIJ Offshore Leaks database, node 80118832

Inquiry 140 Unanswered

Rovida Asset Management Limited — described as having been founded in 1992 as 'Rosenwald, Roditi & Company, Ltd.' by James B. Rosenwald III and S. Nicholas Roditi, and later renamed, appearing in the Paradise Papers — including its history, its relationship to the present Dalton fund complex, and whether its assets were consolidated into Dalton.

Reference: ICIJ Offshore Leaks database, node 82001548

Inquiry 141 Unanswered

Rovida Holdings Limited and Rovida Advisors Holdings Limited, which appear in the Paradise Papers, and their role within the Rovida/Rosenwald structure.

Reference: ICIJ Offshore Leaks database, nodes 82007158 and 82019470

Inquiry 142 Unanswered

Rovida Estates Limited — a Cayman Islands entity associated with real-estate/property holdings (c/o The London & Amsterdam Trust Company, Camana Bay, Grand Cayman) that appears in the Paradise Papers — including its holdings and any relationship to the marital-estate assets.

Reference: ICIJ Offshore Leaks database, node 80119152

Inquiry 143 Unanswered

Dalton Investments Limited — a Barbados entity distinct from the U.S. Dalton entities that appears in the Paradise Papers — including its purpose and relationship to the U.S. Dalton investment business.

Reference: ICIJ Offshore Leaks database, node 100606650

Inquiry 144 Unanswered

S. Nicholas Roditi and N. Roditi & Co., which appear in the Paradise Papers in connection with the Rovida entities, and the nature of the Roditi relationship to the Rosenwald investment enterprise.

Reference: ICIJ Offshore Leaks database, nodes 80118292 and 81029859

Inquiry 145 Unanswered

Rosenwald Group Ltd., which appears in the ICIJ Offshore Leaks records, and its jurisdiction, ownership, and purpose.

Reference: ICIJ Offshore Leaks database, node 195016

Inquiry 146 Unanswered

The scope of the law firm Appleby's engagement servicing the foregoing offshore entities (the source of the Paradise Papers records), and the beneficial-ownership reporting associated with these entities.

Reference: ICIJ Offshore Leaks database (Paradise Papers / Appleby records)

Inquiries 147–150

Additional Preliminary Inquiries — Further Information Welcomed

The following inquiries rest on preliminary or partial information drawn from public records, and I include them in the same good-faith, exploratory spirit; I would particularly welcome correction or clarification on any of them.

Inquiry 147 Unanswered

Beach View Property Ltd. (a Barbados entity) and Beach Bay Holdings, which appear in the Paradise Papers, and whether either has any relationship to Beach Front Properties or to the family's real-estate interests.

Reference: ICIJ Offshore Leaks database, nodes 100328701 and 82012385

Inquiry 148 Unanswered

Whether the Cayman real-estate vehicle Rovida Estates Limited has any relationship to the Beach Front or Glass House real-estate interests.

Reference: ICIJ Offshore Leaks database, node 80119152

Inquiry 149 Unanswered

The terms of the February 2024 conversion of Dalton Investments LLC to Dalton Investments, Inc. and the July 2024 transaction by which Rosenwald Capital Management became the majority owner of Dalton, and whether any beneficial interest connected to this household was diluted, redeemed, or otherwise affected.

Reference: SEC Form ADV filings for CRD 109538 and 308609; Nevada and Delaware corporate filings

Inquiry 150 Unanswered

Whether the management business of Rovida Asset Management was consolidated into the Dalton complex, and if so, on what terms and with what effect on the value of the enterprise.

Reference: ICIJ Offshore Leaks database, node 82001548; SEC Form ADV history

Provenance

The letter of inquiry is dated June 21, 2026 and comprises 150 numbered inquiries over 27 pages, transmitted together with a three-volume evidence binder of the primary-source records — the same corpus preserved in this archive's source documents collection. The register above reproduces each inquiry's subject matter and source reference; the identical good-faith wrapper language is described once in the note at the top of this page. Status is updated when a substantive answer is received.